SEC EDGAR Filing Information

Form SC 13G -- Statement of acquisition of beneficial ownership by individuals

Filing Date Changed: 2008-12-03
Documents: 1

SEC Accession No.
0000950162-08-000526
Filing date: 2008-12-03
Accepted: 2008-12-03 16:52:42

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13G	claudio13g_112608.htm	239543	CLAUDIO CAVAZZA/DOR DIOPHARMA - SCHEDULE 13G

		0000950162-08-000526.txt	241375	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Subject) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 081227947
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628

CAVAZZA CLAUDIO (Filed by) (0001164803)
Type: SC 13G | Act: | Film No.:

Business Address

Mailing Address
VIA SUDAFRICA 20
ROME ITALY L6 00000